Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.
T J Manski, D K Heffner, G M Glenn...
https://pubmed.ncbi.nlm.nih.gov/9145719Completed
All Genders
ID00001171
Evaluation of Biological, Immunological and Therapeutic Parameters in Brain Tumor Patients
Led by National Institute of Neurological Disorders and Stroke (NINDS) · Updated on 2008-03-04
800
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Presently, patients with primary malignant brain tumors have a life expectancy of 15 weeks following surgery unless they receive additional types of therapy (chemotherapy, radiotherapy, and/or immunotherapy). Patients that receive additional therapy can increase life expectancy to 50 weeks. The statistics on the life expectancy and survival have increased efforts among researchers to develop new treatments for primary malignant brain tumors. This research project involves the growth and study of human brain tumor cells outside the body in the laboratory as part of an attempt to better understand these tumors and to develop more effective treatments for them.
CONDITIONS
Official Title
Evaluation of Factors in Human Brain Tumors
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
INCLUSION CRITERIA:
Patients to be studied will have either undergone surgical confirmation of a malignant primary brain tumor or be considered likely to have that diagnosis on the basis of diagnostic studies.
They should have survival likelihood of at least three months and be able to comprehend the nature of the proposed program.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
Trial Site Locations
Total: 1 location
1
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States, 20892
Status Unknown
Loading map...
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function.
R B Mason, L K Nieman, J L Doppman...
https://pubmed.ncbi.nlm.nih.gov/9285597Hyperosmolar blood-brain barrier disruption in baboons: an in vivo study using positron emission tomography and rubidium-82.
B Zünkeler, R E Carson, J Olson...
https://pubmed.ncbi.nlm.nih.gov/8609564